Doi Naoya, Miura Tomoyuki, Mori Hiromi, Sakawaki Hiromi, Koma Takaaki, Adachi Akio, Nomaguchi Masako
Department of Microbiology, Graduate School of Medical Sciences, Tokushima University, Tokushima, Japan.
Laboratory of Primate Model, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Front Microbiol. 2018 Oct 18;9:2510. doi: 10.3389/fmicb.2018.02510. eCollection 2018.
A major issue for present HIV-1 research is to establish model systems that reflect or mimic viral replication and pathogenesis actually observed in infected humans. To this end, various strategies using macaques as infection targets have long been pursued. In particular, experimental infections of rhesus macaques by HIV-1 derivatives have been believed to be best suited, if practicable, for studies on interaction of HIV-1 and humans under various circumstances. Recently, through genetic manipulations and viral cell-adaptations, we have successfully generated a series of HIV-1 derivatives with CXCR4-tropism or CCR5-tropism that grow in macaque cells to various degrees. Of these viruses, those with best replicative potentials can grow comparably with a pathogenic SIVmac in macaque cells by counteracting major restriction factors TRIM5, APOBEC3, and tetherin proteins. In this study, rhesus macaques were challenged with CXCR4-tropic (MN4/LSDQgtu) or CCR5-tropic (gtu + A4CI1) virus. The two viruses were found to productively infect rhesus macaques, being rhesus macaque-tropic HIV-1 (HIV-1rmt). However, plasma viral RNA was reduced to be an undetectable level in infected macaques at 5-6 weeks post-infection and thereafter. While replicated similarly well in rhesus peripheral blood mononuclear cells, MN4/LSDQgtu grew much better than gtu + A4CI1 in the animals. To the best of our knowledge, this is the first report demonstrating that HIV-1 derivatives (variants) grow in rhesus macaques. These viruses certainly constitute firm bases for generating HIV-1rmt clones pathogenic for rhesus monkeys, albeit they grow more poorly than pathogenic SIVmac and SHIV clones reported to date.
目前HIV-1研究的一个主要问题是建立能够反映或模拟在受感染人类中实际观察到的病毒复制和发病机制的模型系统。为此,长期以来一直在探索各种以猕猴为感染对象的策略。特别是,人们认为,如果可行的话,用HIV-1衍生物对恒河猴进行实验性感染最适合用于研究HIV-1与人类在各种情况下的相互作用。最近,通过基因操作和病毒细胞适应性改造,我们成功地产生了一系列具有CXCR4嗜性或CCR5嗜性的HIV-1衍生物,它们在猕猴细胞中具有不同程度的生长能力。在这些病毒中,那些具有最佳复制潜力的病毒可以通过对抗主要限制因子TRIM5、载脂蛋白B编辑酶催化多肽样3(APOBEC3)和束缚素蛋白,在猕猴细胞中与致病性猴免疫缺陷病毒(SIVmac)相当程度地生长。在本研究中,用CXCR4嗜性(MN4/LSDQgtu)或CCR5嗜性(gtu + A4CI1)病毒对恒河猴进行攻击。发现这两种病毒能有效感染恒河猴,即恒河猴嗜性HIV-1(HIV-1rmt)。然而,在感染后5 - 6周及之后,感染猕猴的血浆病毒RNA降至不可检测水平。虽然MN4/LSDQgtu和gtu + A4CI1在恒河猴外周血单个核细胞中的复制情况相似,但MN4/LSDQgtu在动物体内的生长情况比gtu + A4CI1好得多。据我们所知,这是第一份证明HIV-1衍生物(变体)能在恒河猴体内生长的报告。这些病毒无疑为产生对恒河猴致病的HIV-1rmt克隆奠定了坚实基础,尽管它们的生长情况比迄今报道的致病性SIVmac和猿猴-人免疫缺陷病毒(SHIV)克隆要差。